VANCOUVER, BC and
March 20, 2012 /PRNewswire/ - Asantae Holdings International Inc. (TSXV: JVA, OTC PINK: ASNHF) ("Asantae" or the "Company"), a producer and marketer of innovative nutritional products through a network of independent distributors, today recapped the recent media exposure that Dr.
Dwight Lundell, author of "The Cure For Heart Disease" and formulator of Asantae's RealW8™, received on Fox News Channel and
Rush Limbaugh's radio show.
Dan Lundell, Asantae's CEO, stated that "Dr. Lundell's research and ideas have been central to Asantae's mission of addressing the root cause of obesity through our new lead product, RealW8™. Dr. Lundell is the driving force behind RealW8™ and has been instrumental to its successful launch to date."
Asantae is also the publisher of Dr. Lundell's book, "The Cure for Heart Disease," which has recently moved into the Amazon best-seller category.
To view Dr. Lundell's interviews on Fox News Channel, visit
http://bit.ly/A0uoyh. For a transcript of
Rush Limbaugh's coverage of Dr. Lundell, visit
"The Cure for Heart Disease" is available for purchase at Amazon.com at
Asantae Holdings International Inc. (
) is a producer and marketer of innovative nutritional products through a network of independent distributors (Asantae Independent Affiliates). Asantae's flagship product RealW8™ addresses the primary threat to public health in the industrialized world; overweight and obesity. Asantae's approach to this threat is based on a body of research related to the brain chemistry of addiction, chronic low-grade inflammation and oxidative stresses which, according to scientific and medical research, are the underlying conditions for most modern epidemic diseases (obesity, heart disease, diabetes, stroke, some cancers, etc.).
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts